Status:
TERMINATED
Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
NHS Lothian
Conditions:
Shoulder Dislocation
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
For reduction of dislocated shoulder, sedation with propofol and remifentanil should give satisfactory operating conditions and pain relief, and significantly reduce the time to full recovery, compare...
Detailed Description
Propofol is a recognised agent for sedation and remifentanil is a short acting opioid analgesic. We intend to provide sedation with propofol, 0.5 mg/Kg, and analgesia with remifentanil 0.5 microgram/K...
Eligibility Criteria
Inclusion
- \- Anterior dislocation of the shoulder suitable for manual reduction
Exclusion
- significant other illness
- body weight 25% greater than expected
- fear of oxygen masks
- alcohol intoxication
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00326352
Start Date
July 1 2003
End Date
June 1 2005
Last Update
May 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary
Edinburgh, Midlothian, United Kingdom, EH16 4HA